Pictet Asset Management (UK)’s Juno Therapeutics, Inc. JUNO Stock Holding History

Pictet Asset Management (UK)’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-441,800	Closed	-$20.2M	–	921
2017 Q4	$20.2M	Buy	441,800 +33,532	+8%	+$1.67M	0.05%	383
2017 Q3	$18.3M	Sell	408,268 -55,167	-12%	-$1.88M	0.05%	381
2017 Q2	$10.8M	Buy	463,435 +78,690	+20%	+$1.94M	0.03%	459
2017 Q1	$8.54M	Buy	384,745 +47,267	+14%	+$1.01M	0.03%	495
2016 Q4	$6.36M	Buy	337,478 +35,364	+12%	+$865K	0.02%	538
2016 Q3	$9.07M	Buy	302,114 +121,676	+67%	+$3.79M	0.03%	445
2016 Q2	$7.84M	Buy	+180,438	New	+$7.49M	0.03%	480

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Pictet Asset Management (UK)'s JUNO Position: Q1 2018 in Review

Pictet Asset Management (UK) sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 441,800 shares — an estimated $20.2M sold.

Pictet Asset Management (UK) first reported a position in JUNO in Q2 2016 and held it in 7 quarters. The position peaked at $20.2M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Pictet Asset Management (UK) reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Pictet Asset Management (UK) sold 441,800 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $20.2M.
Pictet Asset Management (UK) first reported a position in Juno Therapeutics, Inc. in Q2 2016 and held it in 7 quarters.
Pictet Asset Management (UK)'s Juno Therapeutics, Inc. position peaked at $20.2M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2018, filed 25 Apr 2018.